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Overview
Protein corona and nanoparticles:
how can we investigate on?
Francesca Pederzoli, Giovanni Tosi,* Maria Angela Vandelli, Daniela Belletti,
Flavio Forni and Barbara Ruozi
Nanoparticles (NPs) represent one of the most promising tools for drug-targeting
a
AQ1
nd drug-delivery. However, a deeper understanding of the complex dynamics
that happen after their in vivo administration is required. Particularly, plasma pro-
teins tend to associate to NPs, forming a new surface named the ‘protein corona’
(PC). This surface is the most exposed as the ‘visible side’ of NPs and therefore,
can have a strong impact on NP biodistribution, targeting efficacy and also toxic-
ity. The PC consists of two poorly delimited layers, known as ‘hard corona’ (HC)
and ‘soft corona’ (SC), that are affected by the complexity of the environment and
the formed protein-surface equilibrium during in vivo blood circulation. The HC
corona is formed by proteins strongly associated to the NPs, while the SC is an
outer layer consisting of loosely bound proteins. Several studies attempted to
investigate the HC, which is easier to be isolated, but yielded poor reproducibility,
due to varying experimental conditions. As a consequence, full mapping of the
HC for different NPs is still lacking. Moreover, the current knowledge on the SC,
which may play a major role in the ‘first’ interaction of NPs once in vivo, is very
limited, mainly due to the difficulties in preserving it after purification. Therefore,
multi-disciplinary approaches leading to the obtainment of a major number of
information about the PC and its properties is strongly needed to fully understand
its impact and to better support a more safety and conscious application of nano-
technology in medicine. © 2017 Wiley Periodicals, Inc.
How to cite this article:
WIREs Nanomed Nanobiotechnol 2017, e1467. doi: 10.1002/wnan.1467
INTRODUCTION
In the last two decades, pharmaceutical researchprograms have developed a progressively growing
interest in nanomedicines for diagnostics, therapeu-
tics and specific drug-delivery1 as confirmed by an
increasing number of nanomedicines fully on market.
In order to speed up the translatability of nanomedi-
cines, understanding their fate in vivo is pivotal.
In vivo, nanomedicines are immediately covered
by proteins from the bloodstream leading to the forma-
tion of what is called the ‘protein corona’ (PC).2,3 When
the PC forms on NPs, it could govern the fate and
successes/failures of nanomedicines in terms of efficacy,
targeting, toxicity, cellular interaction, cellular uptake,
and biodistribution.4–8 Protein composition, architec-
ture and structure are normally characterized by well-
known protocols that have been applied to the PC. The
evidence is that to-date PC (or better ‘protein corona +
nanomedicine’) is poorly characterized in terms of
chemico-physical and structural features. Therefore, in
this review, we aim to comment on the most relevant
possibilities in terms of experimental methodologies to
more completely characterize these new entities, and to
furnish useful data to better predict the fate and effi-
ciency of these drug delivery systems in vivo.
HARD AND SOFT CORONA
The PC is frequently described as being composed by
a ‘hard’ (HC) and a ‘soft’ (SC) portions, with the
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binding force of the proteins to nanomaterial often
considered as the discriminating criterion.9–12 Thus,
the HC is generally defined as ‘the corona composed
by tightly bound proteins that do not readily desorb
from the nanomaterial’, whereas the SC is indicated
as ‘the corona featured by loosely bound proteins’.13
In addition to these definitions,AQ4 Sakulkhu
et al. (2013) separated the total PC of their SPION
into three parts: soft, hard and tightly bound, sug-
gesting the possibility to further discriminate another
level of binding force for protein surrounding the
nanomaterial.14
However, the definition of HC and SC can also
take into account more complex issues relating to
thermodynamic and kinetic matters, the interaction
with nanomaterial and the functional/ biological
responses.
As reported,15 from a thermodynamic point of
view, the HC adsorbs onto the surface of NPs in a ther-
modynamically favorable manner with a large net
binding energy of adsorption (ΔGads). This binding
energy determines the stability of the protein–
nanomaterial complex, as a consequence, proteins that
adsorb with a large ΔGads have a low probability of
desorption and tend to stay associated with the nano-
material.16 On the other hand, proteins that adsorb
with a small ΔGads, easily desorb and return to solu-
tion, as in the case of SC. Thus, it is possible to divide
protein adsorption and desorption into ‘fast’ and ‘slow’
components. According to this idea, Cedervall
et al. modeled total plasma protein adsorption using a
bi-exponential function.17 The Cedervall’s model
implicitly divides protein adsorption and desorption
into ‘fast’ and ‘slow’ components, with its own ‘effec-
tive’ kon and koff. Since the fast and slow components
of adsorption and desorption presumably represent the
hard and soft coronas, in some recent papers,10,13,18
the SC and HC, respectively, are alternatively indicated
with the terms ‘fast component’ and ‘slow component’,
referring to desorption processes. On the other hand,
considering the adsorption process, the fast and slow
terms must be inverted. Adsorption/ desorption times
and kinetic curves are unique to each nanomaterial
and depend on many parameters. In this experiment,
protein desorption to N-isopropylacrylamide/N-tert-
butylacrylamide (NIPAM/BAM) copolymer nanoparti-
cles, showed a mean lifetime of 10 min for the fast
component (SC), and 8 h for the slow component
(HC). However, it remains almost impossible to clearly
establish global standard parameters belonging to fast
and slow components or, in other words, to SC
and HC.
In order to better define the HC and SC,
another debatable aspect consists in the interaction
with nanomaterial. The HC is frequently considered
as the portion of the PC directly interacting with the
nanomaterial and the SC as the external portion of
the PC, which is interacting with the inner HC via
protein–protein interactions. In support of this
vision, Simberg and colleagues identified specific pro-
tein domains as responsible for HC adsorption on
their iron oxide NPs. In particular, the authors attrib-
uted ‘domain 5’ (D5) for the adsorption of high
molecular weight kininogen onto iron oxide nano-
particles.19 The precise mechanisms involved during
adsorption and their relative contributions strongly
depend on the proteins which interact and on the
physicochemical properties of the nanomaterial; thus,
it is very difficult, and not always possible, to deter-
minate the protein domain that interacts with the
nanomaterial, especially if the NPs are incubated in a
complex fluid such as plasma.
It is also necessary to consider that, the HC
results from both protein/protein and protein/nano-
material interactions and that the stability of the PC
is strongly dependent on both the type and the bind-
ing force of proteins forming the HC, and that this
should be known to predict the in vivo behaviour.
Recently, Lynch et al. demonstrated the importance
of the HC on the physiological response to a nano-
material.20 In their experiments, the HC remained
adsorbed onto the nanomaterial during biophysical
events such as endocytosis, and even after transloca-
tion to a new physiological environment. On the con-
trary, the SC rapidly dissociated during translocation
and was quickly lost. Moreover, the HC reflects the
journey of the nanomaterial in the body compart-
ments. For example, a nanomaterial that enters the
blood through the lung may display dramatic differ-
ences in HC compositions, and in the resulting physi-
ological responses with respect to the same
nanomaterial directly injected in the bloodstream.21
However, this biological/functional distinction
between HC and SC is not supported by solid data
concerning the SC, but is only limited on speculations
based on HC results.
Similarly, the dynamics involving the SC equi-
librium after in vivo administration represent a
critical point to define the circulation stability of
nanomaterials.
Overall, a precise and specific distinction
between the HC and SC is hard to be defined due to
poor experimental evidences aiming to univocally
individuate and unambiguously discriminate the cri-
teria. Therefore, multiple characterizations must be
utilized to discriminate between the HC and SC and
more completely understand the role of the PC on
the fate of nanomedicines (Table 1).
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ANALYTICAL METHODS FOR
CORONA EVALUATION
The study of the PC can be separated into different
points of view: analysis of PC structure
(i.e., thickness), protein quantification (quantitative
or semi-quantitative approach), study of protein
affinity and stoichiometry, evaluation of protein con-
formation, analysis of NP–protein interaction and
identification of the PC composition (qualitative
approach). Overall, on the basis of the analytical
methods applied in a study, two different approaches
of investigation could be identified: in situ or ex
situ.15 In situ techniques measure the NPs–PC com-
plex directly into the protein solution where NPs are
dispersed. Following this approach, the excessive
sample manipulation is avoided and the incubation
context is preserved allowing a reliable measurement
of how the PC evolves in real time. On the contrary,
ex situ techniques measure the PC after isolation of
the NPs–PC complex from the physiological enviro-
ment.15 In this contest, different isolation methods
could be applied, depending on the experimental
requirements. The most common used methods are:
• Centrifugation. Based on the different densities
of nanomaterials relative to free proteins, cen-
trifugation is, to-date, the most widely used
method for isolation of the PC around
nanomedicines.22–25 Centrifugation is a simple
and quick isolation method and an efficient
way to retrieve enough proteins for their safe
identification using mass spectrometry analysis,
as the quality of identification is strictly depend-
ent on the available amount of material.
• Size exclusion chromatography (SEC). In order
to isolate the corona in a less perturbing man-
ner, SEC was recently proposed as an alterna-
tive to centrifugation. This technique separates
NP–PC complexes from unbound proteins
through a column containing a porous station-
ary phase. Separation takes place since NP–PC
complexes are larger than the stationary phase
AQ2
pores, do not penetrate into the pores, and elute
before the unbound proteins, which on the con-
trary can enter the pores and require a longer
time to pass through the column.
This isolation method is less disruptive than centrifu-
gation and weakly bound proteins may still be
retrieved after the separation.17,20,26
• Magnetic separation/magnetic flow field frac-
tionation (MgFFF). This particular technique is
based on the elution of magnetic NPs by means
of a chromatography-like method in which the
separation is carried out in a single liquid phase.
MgFFF is characterized by the use of an exter-
nal magnetic field applied perpendicularly to
the direction of sample flow through an empty
and thin ribbon like channel.27 As demon-
strated by Ashby et al., this method allows the
screening of proteins with distinct exchange
kinetics in the corona around NPs. In fact,
MgFFF provides for a separation in non-
equilibrium conditions able to cause continuous
dissociation of the protein–NP complexes inside
the column; that way, the dissociated proteins
are constantly washed away from the com-
plexes by the protein-free mobile phase.18
Analysis of the PC Structure
• Dynamic light scattering (DLS). DLS allows the
determination of the hydrodynamic diameter of
colloidal particles and conjugates. Therefore,
DLS measurements are useful to determine
changes in the diameter of NPs before and after
incubation in a biological environment.22 Sev-
eral studies employed the DLS technique aiming
to evaluate the extent of PC formation, and to
correlate an increase in NP diameter after expo-
sure to serum or plasma to the formation of a
TABLE 1 | Schematic Illustration of Hard Corona and Soft Corona Characteristics
Hard Corona Soft Corona
Tightly bound proteins Loosely bound proteins
"|ΔGabs| #|ΔGabs|
#koff "koff
Directly interacting with nanomaterials Protein–protein interaction (and with nanomaterial too?)
Stable on NP surface and able to influence the functional response Fleeting on NP surface and irrelevant for the functional response
NP, nanoparticle.
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PC around the particle.24,25,28 The main advan-
tage of DLS is the possibility to be used both in
situ and after isolation of the NP–PC complex.
However, in order to give reliable results, DLS
measurements require a monodisperse popula-
tion of NP–PC complexes with homogeneous
shapes as it could strongly affect the hydrody-
namic diameters. Recently, a very elegant
approach on NP–PC complex size determina-
tion was given by Schmidt and co-workers29; in
this paper, the aggregation dynamics as well as
the impact of different chemico-physical proper-
ties of NPs on the PC–NP complex size were
analyzed.
• Differential centrifugal sedimentation (DCS).
DCS is able to separate the components of a
mixture on the basis of their density and size, as
larger and denser objects require lower centrifu-
gal forces to sediment. DCS allows the size dis-
tribution measurements of NP–PC complexes
also in situ, but limits may also be present. In
fact, this technique forces the samples to be
repeatedly centrifuged followed by removal of
the pellet and repeated with increased centrifu-
gal force. Moreover, this technology may risk
exposing the samples contaminations and poor
recovery. This method was applied to determine
differences in size between bare and corona-
coated NP systems.24,25
• Transmission electron microscopy (TEM). TEM
is used to obtain images of the NPs before and
after incubation in a biological fluid with the
scope of determining the thickness of PC
around the NPs. However, this technique
requires a sample preparation, which may affect
the morphology of NP–PC complexes.25 In
addition, counterstaining is required, since the
small size of the NPs and the thin protein layer
may provide insufficient contrast.30
Protein Quantification
• Bicinchoninic acid (BCA) assay. This test com-
bines the reduction of Cu2+ to Cu1+ by peptide
bonds of the protein in alkaline solution with
the selective colorimetric reaction of BCA-Cu1+
able to form a purple complex featured by
absorption at λ 562 nm.31 In the case of PC–NP
complexes, the BCA assay is performed to
determine the total amount of proteins
adsorbed onto NPs after incubation in
plasma.32–34 Advantages of this technique are
represented by its compatibility with several
reagents or buffers present in the samples and
the limited amount of sample required for the
analysis. However, the reaction is time and cost
expensive as the unit cost is higher than for
other colorimetric methods, such as the Brad-
ford assay.31
• Bradford assay. This test detects proteins on the
basis of their binding to Coomassie brilliant
blue, forming a protein–dye complex with a
change in the solution color from red to blue,
due to a shift in the peak absorbance of the dye
from λ 465 nm to λ 595 nm.31 As well as BCA
assay, Bradford assay is employed in the deter-
mination of the amount of adsorbed proteins
onto NPs.35,36 This colorimetric method is
highly sensitive, quick and requires minimal
amounts of sample for the analysis. In addition,
it represents one of the less expensive colorimet-
ric methods for protein quantification.
• Thermogravimetric analysis (TGA). This tech-
nique is commonly used to measure the amount
of weight variation occurring after a thermo-
decomposition reaction in organic or semi-
organic materials. Thus, the overall mass of the
proteins adsorbed onto inorganic NP-surface
can be determined by the loss of weight after
the decomposition reaction.37
Binding Affinity/Stoichiometry and Protein
Interaction
• Fluorescence correlation spectroscopy (FCS).
This technique provides information on both
kinetic and thermodynamic properties of fluo-
rescent molecules in solution, exploiting the
temporal relaxation of the measured fluores-
cence fluctuations and the amplitudes of the
fluctuations, respectively.38 Thus, FCS experi-
ments allow us to measure binding curves by
exposing NPs in nanomolar dilutions to a wide
range of protein concentrations and, thereby,
yield information on the tendency of the protein
to adsorb.39
• Size exclusion chromatography (SEC). This
technique allows determination of the affinity
and lifetime of the NP–protein interaction. Ide-
ally, the separation of proteins and other com-
pounds by SEC is based on the size of the
analytes in solution. Generally, the pore size
and/or geometry restrict access of molecules
based on their Stokes radius. The largest mole-
cules/structures, which are excluded from the
pores, elute first. Subsequent molecules elute in
Overview wires.wiley.com/nanomed
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order of decreasing size.40 In the case of the PC,
if proteins exchange slowly from the particle,
they will elute rapidly with the particles, while
if the exchange is fast, the protein will elute at
the same time as without particles.20
• Isothermal titration calorimetry (ITC). This
method can be applied to measure the stoichi-
ometry, affinity and enthalpy of NP–protein
interaction. In this technique, protein is added
to a NP suspension in the sample cell, and the
difference in heat needed to keep both the sam-
ple and reference cells at the same temperature
is measured. If the concentrations of both NPs
and added protein are known, this technique
provides information on the number of bound
protein molecules per particle, the apparent
affinity and the enthalpy change.17
• Surface plasmon resonance (SPR). SPR provides
information on the adsorption kinetics. In this
technique, NPs are anchored on the gold sur-
face of the sensor chip, and proteins are injected
to flow over the NP-modified surface. SPR mea-
sures the change of oscillation of surface plas-
mon waves that are caused by the adsorption of
molecules onto the metal surface.17,41,42
• Quartz crystal microbalance (QCM). This tech-
nology, based on the piezoelectric effect, mea-
sures the resonant frequency shift correlated to
mass changes at the oscillating quartz surface.
Either proteins or NPs are immobilized onto a
gold surface located on a quartz crystal; the
binding partner is injected into the flow-cham-
ber, passed over the quartz surface and the fre-
quency monitored in real-time. Real-time and
quantitative NP–protein binding profiles are
obtained, and the association and dissociation
constants can be determined by fitting to the
Langmuir adsorption isotherm.43
• Z-potential measurement. Zeta potential is
another approach for the screening of NP–
protein interactions. Adsorbed proteins change
the zeta potentials and the isoelectric points
(IEP) of the particles, and the amount of the
adsorbed protein on particle surfaces could be
correlated with the zeta potential.22
• Computer simulation. Beside the experimental
techniques, computer or in silico simulation of
NP–protein interactions is another possible
strategy to predict PC characterization and
composition. In fact, simulation provides infor-
mation on protein orientation and conforma-
tion with high spatial and temporal resolution
and it is applied to study protein adsorption to
NPs as function of surface ligand structure, sur-
face curvature and protein identity.15
Protein Conformation
• Circular dichroism (CD) spectroscopy. CD
measures the spectra of different protein sec-
ondary structures, as they possess their own CD
spectra in the UV region.44–46 This technique
can provide information on protein structural
changes resulting from the interaction with
NPs, but requires relatively high concentration
of the sample and cannot be applied to complex
protein mixtures.41
• Fourier-transform infrared (FTIR) spectros-
copy. Similar to CD spectroscopy, FTIR allows
the determination of conformational changes of
proteins. The protein secondary structures are
estimated on the basis of the absorption of
amide bonds. Among the amide I, II, and III
bands, the amide I vibrational band
(1700–1600 cm−1) is the most sensitive and fre-
quently used to determine protein conforma-
tion.41 The FTIR method allows the detection
of NP–PC complexes already at a very early
stage as well as highlight conformational
changes during the ongoing aggregation
process.
• Raman spectroscopy (RS). As with FTIR, RS
investigates the vibrational modes of molecules,
giving complementary information. Raman
spectra of proteins consist of bands associated
with the peptide main chain, aromatic side
chains, or sulfur containing side chains. Gener-
ally, RS is preferred to measure the protein–NP
complexes in aqueous solution; moreover,
Raman spectra are more simple than IR spectra
since the localized vibrations of double or triple
bonds or electron-rich groups produce more
intense bands than the vibrations of a single
bond or electron-poor groups.41
• Nuclear magnetic resonance (NMR) spectros-
copy. As is well known, the phenomenon of
nuclear magnetic resonance can provide
detailed information about the structure,
dynamics, reaction state, and chemical environ-
ment of molecules. The application of NMR to
PC characterization allowed residue-specific
structural information regarding the adsorbed
protein to be obtained. In particular, localized
conformational information was obtained
regarding some adsorbed peptides, especially by
means of solid-state NMR.44
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• Differential scanning calorimetry (DSC) spec-
troscopy. DSC measures the heat change associ-
ated with the thermal denaturation of a
molecule when heated at a constant rate. In this
way, DSC measures the enthalpy change (ΔH)
of unfolding that results from heat-induced
denaturation. Thus, information on protein sta-
bility after the NP-adsorption process can be
highlighted.47
• Fluorescence correlation spectrometry (FCS).
This technology can be used to get information
about the protein conformation since the maxi-
mum level in fluorescence emission spectrum
intensity changes correspondingly to the protein
conformation.48
Composition
The identities of the proteins composing the corona
around NPs can be investigated using techniques
such as gel electrophoresis [sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS–PAGE) and
two-dimensional gel electrophoresis (2-DE)] and
mass spectrometry (MS).
It must be underlined that these techniques can
be performed only ex situ, after isolation of the NP–
PC complexes from excess plasma or serum.
• One-dimensional gel electrophoresis (1-DE or
SDS–PAGE). In SDS–PAGE, the protein mix-
ture is separated depending on molecular
weights after exposure to an electric field. The
proteins migrate through a polyacrilamide gel
and are separated according to their size due to
their different electrophoretic mobilities. Pro-
teins must be previously denatured and nega-
tively charged by an anionic detergent (SDS).
After the migration, the proteins can be stained
using different methods, such as Coomassie
brilliant blue or silver nitrate staining. Densi-
tometry analysis can be performed in order to
quantify protein abundance. Molecular weights
of separated proteins can be extrapolated by
comparing the position of the protein bands
with SDS–PAGE profile of a protein molecular
weight marker. This technique is often followed
by mass spectrometry analysis to determine the
identities of the separated proteins.41
• Two-dimensional gel electrophoresis (2-DE).
This technique separates protein samples in two
steps or dimensions. In the first dimension of 2-
DE, named isoelectric focusing (IEF), proteins
are separated accordingly only to their IEP. In
the second dimension, SDS–PAGE, proteins are
fractionated on the basis of their molecular
weights. The bands are then visualized through
a staining method and analyzed for protein
quantification.49 This technique also allows
protein identification, since a 2-DE gel can be
compared to the 2-DE map of proteins.
32,33,49,50
• Mass spectrometry (MS). MS has been widely
applied to identify the proteins of the corona.
In protocols present in the literature,51–53 proteins
need to be first digested into smaller peptides with a
proteolytic enzyme such as trypsin, in order to reduce
the size of the analytes and to produce more suitable
data in agreement to the mass range of the instru-
ment. These peptides are ionized in the ion source
and then introduced into a region of high vacuum.
Ions are separated in function of their mass to charge
ratio (m/z) under either a strong electromagnetic field
or in a long drift tube. The resulting mass spectra
allow the primary sequence of each given peptide in
the mixture to be determined. These data are then
compared against the database of the species used in
the experiment to recover the protein identities.41
With this procedure, MS was applied to identify NP
PCs using gel- and non-gel-based methodologies.
Gel-based techniques require, as first step, a
protein separation on SDS–PAGE: in more details,
the bands of interest are cut from the gel and digested
by trypsin, and then the peptides are analyzed by
mass spectrometry. This technique was widely
employed in order to determine the protein pattern
of the whole PC around NPs.23,24,54
On the other hand, the non-gel-based method
can be applied either on proteins still adsorbed onto
the NPs or after protein desorption. The proteins are
digested by trypsin and the resulting peptides are
directly analyzed by means of MS. Before trypsin
digestion, protein denaturation is always performed
in order to make the domain for trypsin more
accessible.
Overall, both non-gel and gel-based methods
require separation of the peptides before the MS injec-
tion, exploiting, for example, liquid chromatogra-
phy.41 Several approaches were therefore proposed to
this aim: nanoscale liquid chromatography-quadrupole
time-of-flight MS/MS (nLC Q-TOF MS/MS), nanoelec-
trospray liquid chromatography-tandem mass spec-
trometry (nLC-MS/MS), nano-liquid chromatography
MALDI-TOF/TOF, ion trap-mass spectroscopy (IT-
MS) and matrix-assisted laser desorption/ionization
time-of-flightsecondary ion mass spectrometry
(MALDI-TOF-SIMS).23,24,26,36,55–57
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In summary, the discussed techniques for the
investigation of the PC are listed in Table 2.
TECHNICAL APPLICATIONS IN HARD
CORONA STUDY
Table 3 summarizes the identification of the HC fea-
tures for different NPs using the methods described
in the previous section. From a technological point of
view, remarkably, it must be highlighted that HC
analysis necessary requires an ex situ approach. As a
first step, the most used method for HC isolation is
the centrifugation, as illustrate in Figure 1.2 Gener-
ally, it allows the isolation of NP–HC complex, while
weakly bound proteins are lost. However, it is
important to note that the duration of washing as
well as the solution volumes used during the washing
steps could impact the final results, and that the most
abundant proteins, or protein aggregates, may be
recovered after sedimentation at the bottom of the
centrifugation tube due to in-correct washing.2,15
Only a limited number of papers described the appli-
cation of different isolation methods such as gel
filtration,70 size exclusion chromatography,17 and
magnetic separation14,18,70 in order to characterize
the HC.
HC Structure and Quantification
As reported in the literature, after the removal of the
SC, it is possible to analyze the HC in terms of thick-
ness or increase in mass percentage.23,58,71 The evalu-
ation methods are almost the same independently of
the kind of NPs (i.e., inorganic or organic polymeric
NPs). For example, Casals et al. noted that the diam-
eter of gold NPs (initially 10 nm) changed when
incubated in fetal bovine serum. In particular they
highlighted that a long incubation time (48 h) lead to
a stable protein coating on the NP surface, which
produced an increase in diameter of more than 50%
in respect to the initial diameter.22 On the other
hand, Monopoli et al. demonstrated that the thick-
ness of the HC in polystyrene NPs could change on
the basis of plasma concentrations used in the experi-
ment: a higher plasma concentration leads to a
thicker HC (38% hydrodynamic diameter
increase).24 This observation was confirmed by Car-
acciolo et al. in the case of 1,2-dioleoyl-3-
trimethylammonium propane/DNA NPs incubated in
a concentrated solution of plasma, which led to the
detection of a thicker total PC (31% of hydrody-
namic diameter increase).72 All of these measure-
ments were obtained by DLS analysis, the most
applied technique in order to identify HC thickness.
TABLE 2 | Schematic Illustration of the Main Techniques Used for the Characterization of Different PC-Related Parameters
Parameter Technique(s)
Structure/thickness Dynamic light scattering (DLS)
Differential centrifugal sedimentation (DCS)
Transmission electron microscopy (TEM)
Protein quantification Bicinchoninic acid (BCA) assay
Bradford assay
Thermogravimetric analysis (TGA)
Binding affinities/stoichiometry and NP–protein interaction Fluorescence quenching titration
Fluorescence correlation spectroscopy (FCS)
Size exclusion chromatography (SEC)
Isothermal titration calorimetry (ITC)
Surface plasmon resonance (SPR)
Quartz crystal microbalance (QCM)
Zeta potential (Z-pot)
Computer simulation
Protein conformation Circular dichroism (CD)
Fourier-transform infrared (FTIR) spectroscopy
Raman spectroscopy (RS)
Nuclear magnetic resonance (NMR)
Differential scanning calorimetry (DSC)
Fluorescence correlation spectrometry (FCS)
PC composition Sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE)
2D-PAGE
Mass spectrometry (in-gel method)
Mass spectrometry (non-gel method)
NP, nanoparticle; PC, protein corona.
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However, it is worth mentioning that centrifugation
cycles, performed in order to isolate the HC–NP
complex, could lead to aggregation phenomena.
Inevitably, these aggregates could dramatically affect
the results obtained by DLS and the final thickness
should not be considered as comprehensive of the
whole sample. As an example, Wang and colleagues
observed a change in both size dimension and distri-
bution of gold-NPs after serum incubation; particu-
larly, the average diameter of NPs dramatically
increased from 25 to 83 nm and distribution become
more heterogeneous. They hypothesized that the
increase in NP diameter was not only due to the for-
mation of HC, but also to the presence of NP–
protein agglomerates, caused to the presence of Ca++
and Mg++ ions present in the medium.58
To complement the information given by DLS,
TEM analysis can be applied to furnish structural data,
as reported by Walczyk et al.25 The authors compared
polystyrene NPs before and after plasma incubation,
evaluating the dimensions of about 500 NPs for each
kind of sample (bare and protein-coated NPs) to reach
statistically consistent results. The DLS results indi-
cated that that after plasma incubation, the shell thick-
ness values increased roughly 5–10 nm, but TEM
images did not give the same output, as also reported
by Dobrovolskaia et al. using gold NPs.55 This differ-
ence was probably due to the different technology
applied; TEM measures NP size on a grid support
while DLS evaluate the hydrodynamic diameter of NPs
in suspension. However, in this case, TEM analysis
was considered useful to prove that plasma incubation
did not change the agglomeration state of the NPs and,
as a consequence, that DLS analysis was not affected
by particle agglomeration phenomena.55 This shows
the importance that attention must be given to the
experimental conditions and especially to the analytical
times.73
Moreover, the extent of protein coating form-
ing the HC can be expressed not only as ‘thickness
values’, but also quantitatively. Generally, colorimet-
ric assays are employed (i.e., BCA and Bradford) to
measure the HC protein amount on NPs36,57 or,
inversely, the non-adsorbed proteins left in the
medium.35
Alternatively, Clemments et al. used TGA anal-
ysis to characterize the mass percentage of the HC on
their spherical dense/mesoporus silica NPs. In this
case, the total amount of adsorbed protein was calcu-
lated as a function of weight loss. The data results
and reliability of these results are still debatable. In
fact, as expected, the smallest particles were found to
adsorb the greatest amount of protein, due to the
greater surface area (when equal weights of NPs were
used). However, by normalizing the total amount of
adsorbed protein to the total surface area of each
sample, the results clearly stated that an increase in
particle diameter greatly increased the amount of
adsorbed protein. Thus, the authors hypothesized
that a decreased surface curvature of larger particles
could favor protein binding, as proteins are able to
pack together more closely.37
Binding Affinities/Stoichiometry and NP–
Protein Interaction
Data related to the layer thickness of the HC is frequently
reported in scientific researches.22,24,25,55,58,72,74,75
On the contrary, the absolute number of bound
FIGURE 1 | Schematic illustration of hard corona (HC) studies. This kind of analysis requires an ex situ approach (generally by centrifugation).
After this first step, the HC characterization is continued with different analytical pathways. Data collected from all these investigations could give
a complete pool of information about HC features.
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proteins and their exchange dynamics in body fluids
are difficult to be assessed with standardized
protocols.
In particular, regarding the HC, we are limited
by a lack of information on the dynamics of protein
exchange, mainly due to a shortage of techniques
that allow the assessment of the binding and unbind-
ing of specific proteins to NPs.60 To overcome this
drawback, Yang et al. elaborated on a two-step fluo-
rescence quenching experiment aiming to quantify
the binding affinity of the HC for gold-NPs incu-
bated with a single protein solution [α-synuclein
(α-syn)].59 Briefly, in the first step, different concen-
trations of gold-NPs were titrated against a known
concentration of α-syn obtaining the first fluores-
cence quenching plot. Coated gold-NPs used in this
first titration were then collected, purified
(by centrifugation) and used in the second titration
set against the same amount of α-syn (second fluores-
cence quenching plot). Authors assumed the fluores-
cence quenching obtained in this second step was the
combination of the gold-NPs and SC light absorp-
tion. The difference between the first and second flo-
rescence plots was then due solely to the HC of α-syn
on gold-NPs and it was used to calculate HC binding
constant.
Alternatively, Milani et al. used FCS to measure
HC binding rate overtime in terms of the number of
transferrin molecules bound per particle to sulfonate
(PSOSO3H) and carboxyl- (PSCOOH) polystyrene
NPs. The authors found that the fraction of mole-
cules (proteins) bound to the NPs could be described
with a universal adsorption curve if plotted as a func-
tion of molar protein-to-NP ratio. In particular, this
adsorption curve was characterized by a two time-
scale dynamic due to a first strongly bound mono-
layer (namely HC) and to a second weakly bound
layer (namely SC). Thus, they demonstrated that the
HC was characterized by an off rate longer than the
experimental time scale of a few hours, while the SC
appears to exchange proteins within minutes under
buffered conditions.60
The binding affinity or the exchange rate of the
proteins belonging to PC are generally investigated in
a comparative manner; this method does not imply a
clear distinction between HC and SC, but it allows
bound proteins to be ordered on the basis of their
affinity to the NPs. As an example, a recent study by
Winzen and co-workers applied ITC to characterize
PC binding affinity around hydroxyethyl starch
nanocapsules. Results revealed large amounts of
human serum albumin (HSA) amount present with
low binding affinity, probably ascribable to the SC;
on the contrary, apolipoprotein A-I was present in
small amounts but with high binding affinity, typi-
cally considered as a HC component.61
In addition, there have also been a huge num-
ber of studies evaluating NP-protein dynamics, which
provided information not necessarily related to the
binding affinity constants. One example assessed the
dynamics and evolution of the PC–NPs at different
incubation times by evaluating zeta potential
values,62 zeta potential and QCM,43 or by zeta
potential and SPR analysis.22 In the latter case,
depending on time of incubation, SPR measurements
shifted over time thus, revealing the formation of a
dense dielectric layer around gold NPs due to the
adsorption of proteins onto the NPs surface.22
Protein Conformation in the HC
Curved NP surfaces in comparison with planar sur-
faces are known to be able to provide extra flexibility
and enhanced surface area to the adsorbed protein
molecules.76 However, only in the recent years has
the attention focused on the impact of different NPs
surfaces ‘architectures’ on protein conformation. In
particular, curved NP surfaces were demonstrated to
affect the secondary structures of proteins, and, in
some cases, causing irreversible changes.77 This phe-
nomenon is particularly relevant when considering
the biological fate of NPs, due to obvious implica-
tions for clearance and immunological responses.
Thus, a number of studies have attempted to investi-
gate on the conformational changes of the proteins
adsorbed onto NPs. All the studies referred to the
proteins composing the HC layer, the structure clo-
sest to nanomaterial, which are affected by modifica-
tions of secondary structures in function of surface
changes. Aiming to use CD spectroscopy to investi-
gate the interaction of polystyrene NPs with cellular
receptors after adsorption of BSA, Fleischer and
Payne demonstrated that the secondary structure of
adsorbed BSA is strongly responsible for the interac-
tion of the complexes with the receptors.11 Also,
Wangoo et al. performed CD experiments and found
that BSA undergoes to conformational changes in a
dose dependent manner when incubated with gold
NPs.63 Mahmoudi et al. used the same technology to
study the interactions of iron saturated human trans-
ferrin protein with both bare and polyvinyl alcohol-
coated superparamagnetic iron oxide nanoparticles
(SPIONs).41 In this case, the exposure of human
transferrin to SPIONs led to a protein conforma-
tional change, from a closed to open conformation,
causing the release of iron by the protein. This new
conformational state was also maintained after the
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removal of the magnetic nanoparticles indicating the
changes in transferrin structure were irreversible.41
As a general consideration, CD technology can
be considered a powerful analytical tools in deter-
mining the protein conformation in solution or when
adsorbed onto other structures. This is confirmed by
the large number of studies reporting CD spectros-
copy to study protein conformational changes. How-
ever, data coming from CD analysis can be
supported by other analytic methods such as
NMR.44 For example, Lundqvist et al. studied the
conformational change of the protein HCAI
adsorbed onto the surface of silica NPs. Through
NMR and near-UV CD, the authors were able to
demonstrate that longer incubation times correlated
with a gradual shift of the native HCAI to a more
disturbed conformational form.44
Another technique often employed in the deter-
mination of protein conformation is represented by
FTIR. In a recent work, Ma et al.72 used FTIR to
investigate the adsorption of human albumin (HSA),
globulin (HGG), and fibrinogen (HSF) onto different
kinds of mesoporous silica nanoparticles (MSNs).
The authors found that the conformation of
absorbed HSA and HSF is affected by the pore size
and morphology of their MSNs; on the contrary,
HGG conformation was not affected by adsorption.
Moreover, these conformational changes of the
adsorbed proteins were able to affect the saturated
adsorption capacity of the NPs.65 In another
research, the FTIR method was employed in associa-
tion with highly sensitive DSC to determine
adsorption-induced structural changes of the same
model proteins [BSA, lysozyme (LZM) and fibrino-
gen (FBG)] on different ceramic nanoparticles. In
almost all cases, protein adsorption resulted in desta-
bilization and structural loss of the bound proteins.
In particular, a loss in α-helical structure seemed to
be the most sensitive structure on adsorption-induced
rearrangements. Moreover, the authors conclude that
the two techniques applied in the study (DSC and
FTIR spectroscopy) were able to provide complemen-
tary information on adsorption-induced structural
changes. Specifically, DSC was identified as the most
suitable technique in order to provide information
about the molecular level (thermal stability, overall
structure) while FTIR gave relevant information on
the sub-molecular level (secondary structure).47
Alternatively, Raman spectroscopy (RS) can be
used to evaluate the occurrence of conformational
changes. Recent experiments revealed that a signifi-
cant shift of the amide-I band could be observed after
incubating silica NPs with a BSA protein solution,
whereas, other model proteins maintained their
native conformations, after adsorption onto the sur-
face of the NPs (RNase and HEL), under the experi-
mental conditions employed.66
Apart from the structural information obtained
by CD, FTIR, NMR and RS analysis, some indica-
tions about protein conformation changes can be
achieved by using FCS. Some authors exploited FCS
to investigate the effect of titanium dioxide (TiO2)
NPs on microtubules polymerization since the tubu-
lin is able to produce a fluorescence quenching and a
blue shift of the maximum emission wavelength after
the incubation with TiO2 NPs. As evidence, the
authors concluded that TiO2 NPs were able to inhibit
tubulin polymerization, thus confirming that NPs
lead to protein function alteration by inducing
changes in protein folding.67
HC Composition
In order to detect the composition of the HC, after
isolating the NP–HC complex from the excess of pro-
tein in the media, a preliminary desorption process of
the proteins from the nanomaterial surface, generally
named ‘ex-particle’ protocol, can be required. Protein
desorption from the nanomaterial can be performed
by treating the HC–NPs complex with high tempera-
tures, high salt concentrations or detergents to detach
them from the complex and make them suitable for
the analysis (protein electrophoresis or enzymatic
digestion followed by MS). Alternatively, the ‘on-par-
ticle’ protocol can be adopted to by-pass the desorp-
tion procedure, but it requires an enzymatic digestion
performed on NP surface. This method is particularly
useful when the strength of the interaction between
the protein and the nanomaterial could cause a par-
tial detachment during desorption leadingto unsatis-
factory results.
Generally, the protein desorption method of
choice must take great account into the final aim, the
technical procedures which are compatible with the
samples, the raw materials and the experimental
features.
Sempf et al.57 chose to apply an ‘on particle’
approach to the analysis of the HC formed on poly-
lactic-co-glycolic acid (PLGA)-NPs after incubation
in human plasma. The proteins were directly digested
on the NP surface using trypsin and then analyzed by
nLC MALDI-TOF/TOF (without gel analysis).57 The
authors identified 15 proteins in the HC, 7 of which
were not typically abundant in plasma. Moreover the
authors compared their results with those obtained
by other authors49 using other methodologies to
investigate the HC of PLGA-NPs. The results were
strikingly different within the two experimental sets,
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particularly regarding the presence of proteins such
as albumin, Apo A-1, Apo A-4, Apo C-3, and trans-
ferrin. Maybe, as explained above, these differences
could be ascribable not only to the features of the
NPs (size, surface curvature, etc.) but also to the
applied analytical method (on-particle vs ex-particle
digestion/in-gel vs non-gel approach).
Other papers described the combined method
of SDS–PAGE followed by MS23,24,37; one of the
most complete work dealt with the detection and
evaluation of the HC of NIPAM-BAM NPs with
varying sizes (70–700 nm) and polymers ratios,
finally identifying HSA, apolipoprotein A-IV, apoli-
poprotein A-I and apolipoprotein A-II as the most
consistently present proteins composing the HC
around these NPs.26 Another research group
employed 2D-PAGE and Western blotting analysis to
compare the HC profile of pegylated- polyhexadecyl-
cyanoacrylate (PHDCA) NPs to non-pegylated
PHDCA-NPs. The results revealed that, after incuba-
tion with rat serum, apolipoprotein E (ApoE)
adsorbed more onto PEG-PHDCA than on PHDCA
nanoparticles.68
As also remarked by Walkey and Chan, some
proteins adsorb abundantly to every nanomaterial,
while other proteins do not. The abundant proteins
in the HC are not always the same and it is strictly
dependent on the NP feature and experimental condi-
tion adopted. It is also important to note that the
total number of unique proteins within the PC of any
nanomaterial is unknown. While LC–MS/MS is more
sensitive, and tends to detect more low abundance
proteins, neither PAGE nor LC–MS/MS is sensitive
to the single molecule level.15
Interestingly, a recent work proposed an up-
graded method by combining SDS–PAGE/MS to
obtain time-resolved HC profiles formed on various
NPs.51 Briefly, after NP incubation in protein contain-
ing medium, NP–protein complexes were rapidly sepa-
rated from unbound proteins by sedimentation
through a sucrose cushion, and washed to obtain the
HC–NP complex. Subsequently, the protein desorption
and separation could be obtained via 1D SDS–PAGE
in association with an immunoblot analysis to identify
and (semi)-quantify the presence of specific corona
proteins. Alternatively, the authors proposed a proto-
cols based on protein desorption and digestion with
trypsin followed by resolution of the obtained peptides
by high-resolution nanoscale ultra-performance liquid
chromatography on reversed-phase (C18) columns,
analyzed by ion mobility-enhanced data-independent
acquisition (DIA) MS. This complex protocol could
give interesting improvements since the sucrose cush-
ion centrifugation method efficiently limits the contact
time of NPs with the biological fluid of interest, render-
ing analyses of short time periods feasible. Moreover,
the adapted label-free quantification by LC–MS (taken
by the recently described ion mobility-enhanced, DIA-
based label-free quantitative proteomics workflow of
Distler et al.)78 allows reliable and highly reproducible
quantification of corona components. Moreover, the
authors specified that the protocol could be readily
extended to the investigation of PCs from various
nanomaterials, as confirmed by the application of this
protocol to different silica nanoparticles and polysty-
rene nanoparticles.51,69
TECHNICAL APPLICATIONS IN SOFT
CORONA STUDY
An overview of studies referring to SC characteriza-
tion is reported in Table 4. In comparison with the
HC, a limited number of methods for SC detection
are available. As a consequence, poor knowledge
concerning the SC is present.
The major drawback is the SC isolation. In fact,
the common isolation methods, inevitably, stress the
NP–PC complex resulting in a partial, or sometimes
total, detachment of the SC. As a matter of fact,
almost a totality of studies on the SC relied upon in
situ techniques (previously described) and is mostly
focused on the identification of the SC structure, with
the exclusion of a few exceptionally complex experi-
mental procedures (Figure 2). To-today SC character-
ization still represents an intriguing challenge.
SC Structure and Quantification
The major part of studies concerning the SC structure
provide the measurement of the total PC thickness
depleted of HC contribution. However, this indirect
measurement needs to be carefully evaluated in order
to avoid unreliable results and therefore, presents
several criticisms such as the congruity of time, con-
dition and methods of analysis for total PC and HC
thickness. In fact, it is obvious that the comparison
between in situ and ex situ measurements could pro-
vide only an approximation regarding the SC struc-
ture since it is not possible to compare measurements
performed in a suspension medium with a different
diffraction index, a concept often neglected in some
PC studies.22 Considering this gap, a clear study of
the SC structure and thickness only by DLS analysis
is not an easy thing to manage. Schaffler et al. tried
to by-pass this gap by incubating gold NPs in a
diluted serum solution (1:100 in PBS buffer).79 With
this protocol, the measurements performed in situ are
more comparable with the measurements performed
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after the centrifugation and re-suspension procedures.
The data obtained from the incubation in situ experi-
ment showed an increased hydrodynamic diameter of
the gold NPs; this increase remained unchanged even
after centrifugation and re-suspension. The lack of size
reduction after centrifugation is interpreted as a techni-
cal limit of DLS in measuring the labile part of the PC
(alias SC), as only the HC was detected before and
after the purification processes.
Thus, in this case, DLS analysis is not strongly
affected by different incubation media diffraction
indices of, but the incubation in diluted plasma could
lead to an incomplete coverage of proteins around
the NPs. In fact, total plasma incubation better simu-
lates the in vivo conditions that give a large excess of
proteins occurring to saturate the surface of NPs,
while a deficit of protein concentration in the incuba-
tion medium can explain the behaviour of gold NPs.
DCS represents the other mainly elective
method to study the SC; with respect DLS, the DCS
technique is limited by the requirement of applying a
mathematic model. For example, aiming to identify a
reliable size by DCS, one must know the shape and
internal density distribution of each aggregate. To
overcome this problem, researchers present their data
by correlating the equivalent diameters for spheres of
homogeneous density and relative ‘apparent’ molecu-
lar weight.25 Thus, the ‘true’ size of the NP–protein
complex and the corona size were computed on mon-
omeric NPs–protein complexes using a simple core–
shell model of two densities (bare particle material
density and adsorbed protein-biomolecule density).
This core–shell model is generally the most used for
these experiments.81,82 It is a simple model to analyze
data for shell-coated particles and to get an estima-
tion of the shell thickness. In this case, the shell is
represented by the PC. In this study, the PC of poly-
styrene NPs was measured under several different
conditions including full plasma (diluted in PBS),
after washing, centrifugation, and re-suspension in
PBS buffer, thus enabling washing-off of the excess
(unbound or loosely bound) proteins. In the presence
of excess plasma, these different experimental condi-
tions allowed the authors to draw connections
between the NP–corona complexes in isolation and
in situ, to finally refer to the presence of the SC. The
DCS method was applied in the experiment on both
silica and polystyrene NPs after plasma incubation.24
Interestingly, after centrifugation no difference in NP
size was reported, but only a reduction of the PC
thickness, inversely proportional to the plasma con-
centration, was observed.
Overall, the experiments described above
clearly showed that, independent of the NP charac-
teristics (material composition, size) and incubation
conditions (time and temperature), both techniques
(DLS and DCS) are able to describe the increase in
NP diameter after plasma incubation. However, dis-
criminating between HC and SC is not always so
clear. In opposition with Casal’s work, Schaffler’s
group declared the impossibility to measure the SC
by DLS.79 Other researchers25 tried to calculate the
SC contribution in PC thickness by an indirect
method in which the diameter of the HC, calculated
by core–shell model, was subtracted from the total
diameter is measured by DCS; in this experiment,
data seemed to support the efficacy of DCS method
for SC structure determination.
FIGURE 2 | Schematic illustration of soft corona (SC) studies. The major part of the studies are based on in situ approach (solid black arrow),
with the exception of a few cases based on ex situ approach (dashed arrow). The information given by the SC analysis are more limited or
completely missing in number if compared with HC analysis (if considering protein conformation analysis). Moreover, SC data are generally
obtained by the measurement of the total PC subtracting the HC (as indicated by the double arrows in the upper part of the scheme).
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Generally, the experimental data related to SC
analyses appear discordant, and the differences in the
definition of the SC (as debated above in paragraph
2) strongly generate confusion and, as a consequence,
different manners of interpreting the data. Similarly,
the discrepancy of results concerning the SC is cer-
tainly due to the lack of a fine method of detection,
able to appreciate slight differences in terms of size as
well as to monitor the quickly evolving and mutable
binding states of the SC. Moreover, it is interesting
to note that the major part of this investigation on
SC structure belongs to experiments on inorganic
NPs such as SPION, silica and gold NPs. The major
dispersion in size distribution of organic polymeric
NPs is probably one of the critical point that limits
PC studies on these particles; data relating their
in vivo behaviour are poor or totally lacking.
Researching a reliable method to discriminate the SC
contribution to the total PC structure is actually an
urgent issue, especially for organic polymer NPs.
Binding Affinities and Stoichiometry of
Proteins in the SC
The binding and dissociation rates of proteins to NPs
are surely critical parameters for their biological fate.
It is widely accepted that the tightly associated pro-
teins of the HC (with slow exchange rate) may follow
the particle during the endocytosis process, while
proteins of SC (with fast exchange rate) are quickly
replaced by the intracellular proteins, during or
immediately after endocytosis.83 As a consequence,
the SC is generally considered less relevant in govern-
ing the functional response of NPs. However, the
biological outcome may differ if, not only endocyto-
sis process, but also the relative protein exchange
rates between NPs and cellular receptors, are consid-
ered. Because the protein–ligand complexes typically
display lifetimes from microseconds to days,17 it is
feasible that the fast exchanging proteins of the SC
could be strongly involved in determining the biologi-
cal fate of a NP, even if the rates of association and
dissociation are likely to vary quite considerably
depending on the protein and particle type.
As previously reported, methods are generally
oriented to compare the protein exchange rates of
the total PC; in this paragraph, we principally discuss
studies dealing with protein binding affinity in the
total corona, as the discrimination for SC proteins
could only be hypothesized from the total PC
analysis.
In this way, a mathematical dynamic model
was developed aiming to predict the time evolution
and equilibrium composition of the total PC based
on protein affinities, stoichiometries, and rate con-
stants. The authors applied both the theoretical
model and experiment procedures (by SPR technique)
to polymeric NPs (NIPAM/BAM) interacting with
three model proteins [HSA, high-density lipoprotein
(HDL) and fibrinogen]. Experiments indicated that
the PC evolves with time (as predicted by the model),
with evidence of HSA presence in the SC and HDL
presence in HC.80 These findings nicely correlated
with the results previously described on the charac-
terization of the PC binding affinity, where HSA
showed low binding affinity (ascribable to the SC)
around hydroxyethyl starch nanocapsules.61
Moreover, the protein binding affinity study
can be helpful to describe how some NP features
could affect the protein exchange rate of the PC. In
an elegant study, Cedervall et al., using SEC and ITC
techniques, investigated the impact of different copol-
ymer ratios and different rates of hydrophilicity/
hydrophobicity of NIPAM-BAM NPs on the associa-
tion and dissociation of HSA and fibrinogen. Results
suggested that protein dissociation is affected by the
surface properties of NPs (exposition of functional
groups, hydrophilic/hydrophobic surface balance)
and in particular, dissociation was faster considering
the hydrophobic particles.17
However, most of the kinetic modeling of corona
complex formation is operated through in silico stud-
ies. Mathematical modeling helps to learn principles
and to develop quantitative approaches that cannot be
experimentally extracted. Moreover, mathematical
models provide quali/quantitative endpoints, useful for
the design and evaluation of experiments. In this view,
different approaches in the literature are proposed. For
example, Darabi Sahneh et al. presented a model to
describe two-phases of corona complex dynamics,
based on two formulae that predict corona composi-
tion of simulations through insertion of appropriate
parameters depending on features of the NPs.84 The
authors assert that one potential application of this
model would involve a single cell culture medium
related to a complex protein medium, such as blood or
tissue fluid. On the contrary, Vilaseca et al. simulated
molecular dynamics to study the surface adsorption of
proteins. The authors reduced the complexity of a full
modeling by approximating protein molecules as sin-
gle, rigid entities. Kinetic modeling of the corona com-
plex formation process dramatically decreases
computational cost, though adopting several simplify-
ing assumptions. Finally, in silico analysis can be
applied to predict the final in vivo response of NP–PC
complexes.85
In silico prediction analyses were also applied
to predict the evolution and subcellular distribution
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of NPs in living cells84,86,87; the interactions between
NP–PC complexes and cellular membranes were
investigated showing that the PC may enhance phag-
ocytosis of positively charged NPs, but also cause the
loss of targeting activity of both hydrophobic and
positively charged NPs towards cancer cells.
Protein Conformation and Composition of
the SC
As previously reported, the studies on protein confor-
mation are all referred to the HC. In the SC, the pro-
teins, loosely bonded to the NPs surface or
displaying weak interaction with HC, are character-
ized by a fast dissociation rate, making the detection
and full characterization of structural changes partic-
ularly difficult. Similarly, only a few papers describe
the composition of the SC and generally, complex
experimental procedures are required to recognize
the proteins involved.
AQ5 Ashby et al. (2013) presented an alternative
method to analyse the SC consisting of the flow field-
flow fraction (F4) technique.18 Upon incubation with
depleted serum (human serum without albumin or
IgG), half of the NPs were centrifuged for co-
precipitation of ‘all’ bound proteins. The other half
was injected on the F4-column to remove proteins
bound with fast exchange kinetics (SC), thus leaving
only the proteins bound with slow exchange kinetics
(HC) to be co-isolated with the SPIONs. The proteins
collected with the SPIONs were digested and ana-
lyzed by two-dimensional PAGE and nano-LC–MS/
MS for identification. Through mass identification of
the total protein after NP–PC complex centrifugation
and subtracting the protein identified on the surface
of the NPs after F4-column elution, the authors sup-
ply a list of proteins characterizing the SC.
Surely, this method permits the discrimination
of those proteins binding with fast exchanging kinet-
ics, belonging to the SC, but on the other hand it
appears debatable that ‘all’ the proteins forming the
PC can be isolated by centrifugation. Confirming this
lack of clearness, other authors assessed that centrifu-
gation of the NP–PC complex inevitably leads to a
perturbation of the system and, as a consequence, to
the partial loss of the loosely binding proteins.17,88
Alternatively, Sakulkhu et al. proposed a differ-
ent approach regarding SPION-PC characterization.
After the incubation of NPs in serum, SPIONs sur-
rounded by the PC were entrapped into a magnetic
column and the protein was eluted by means of vari-
ous buffers with different ionic strengths, in order to
separate the proteins from the NPs.14 In particular,
to investigate the SC, the researchers applied a first
wash with PBS to separate loosely bound proteins,
followed by washes with solutions of up to 2 M KCl.
Finally, those proteins which remained bound to the
NPs were called ‘tightly bound’ proteins. In this way,
the final result is a triple partition of the total PC:
SC, HC and ‘tightly bound’. Each elution fraction
was analyzed by SDS–PAGE coupled to LC–MS/MS
to protein identification. This technical strategy
allowed for a fine characterization of the whole PC
in general, but in particular, permitted the investiga-
tion of the SC composition. Indeed, the magnetic sep-
aration technique and the magnetic properties of
SPIONs are useful to overcome problems of SC isola-
tion in order to characterize its composition, but, on
the other hand, this technique can inevitably only be
appreciated for a few fields of application. The
obtained results, reported in the article, showed that
‘tightly bound’ proteins were observed only on nega-
tively charged PVA-coated SPIONs after the strong
protein elution. The triple partition of total PC repre-
sents a novelty in this research field and, one more
time, is proof of the great confusion about appropri-
ately defining the PC. Nevertheless, the work of
Sakulkhu et al. is well organized; no parameters exist
to establish what are the HC, SC and ‘tightly bound’
proteins. Thus, the triple partition of the article
results are arbitrary and non-comparable with other
articles in which only a bi-partition of the total PC is
present.81
Apart from SPIONs, the only characterization
attempt for SC composition can be ascribed to
Cedervall et al.17 Using SEC, researchers were able to
distinguish both fast and slow components of the PC
(as discussed above in relationship with binding
affinity of SC proteins). Furthermore, they also were
able to collect the proteins with fast exchange rate
(ascribable to the SC) and characterize them through
SDS–PAGE. In this manner, they compared the NP-
associated protein received after centrifugation and
after SEC isolation. In particular, through SEC pro-
tein isolation, they found that HSA and fibrinogen
concentrations dominate on the particle surface. On
the contrary, apolipoprotein A-I (a lower plasma
abundant protein with higher affinity and slower
kinetics ascribable to the HC) was the most abun-
dant protein recovered after centrifugation.17
INSIDE THE METHODS: LIMITATIONS
AND ADVANTAGES
Aiming to analyse the HC composition, the choice
between ex-particle or on-particle approaches still
remain an open issue. As confirmation of this
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uncertainty, some authors described some defects
and limitation of the ex-particle approach, especially
if the proteins are only identified by 2D-PAGE after
the desorption step.57 In their opinion, the ex-particle
approach can easily allow a sample contamination
by albumin (the most abundant protein in plasma).
Furthermore, 2D-PAGE bases protein identification
on the comparison of the respective spot positions
with a standard reference map. This methodology
may lead to misinterpretation of the data due to
spots overlapping, especially with complex pro-
teomes, like human plasma. Besides this limitation, it
is true that the ex-particle method allows better sam-
ple fractionation as well as multiple analyses
(i.e., electrophoresis tandem-mass spectroscopy) that
lead to a major number of recognized proteins.
So, the main drawback on HC analysis is not
regarding the kind of approach (on-particle or ex-
particle), but how to obtain a solid result independ-
ently from the chosen approach. In this way, a
multiple-technique protocol (i.e., electrophoresis +
mass spectroscopy, or chromatography + electropho-
resis) can represent a good solution.
Beside this aspect, the overlap of different tech-
niques of investigation and advances in instrument
technologies and software has allowed to reach an
earlier mapping of the HC of different NPs on the
basis of size and material composition. There are
review-tables in which it is possible to recognize dif-
ferent type of NPs and the related identified proteins
of the HC.89 One of the most important aspects and
findings is the reproducibility of the data on compa-
rable NPs exposed to similar incubation condition
showing comparable results in terms of the HC
composition.
Regarding the SC analysis method, a shortage
of investigative methods and, as a consequence,
shortage of available data concerning the SC, does
not allow speculation on the weakness and strengths
of the analysis and of the resulting data. In particular
poor specificity, low reproducible rate of results and
poor applicability-range of some techniques designed
‘ad hoc’ for specific typologies of NPs represent the
most important limitations.
Finally, it is worth to mention that almost all
the studies concerning HC and SC have been carried
out in vitro. This is mainly due to the difficulty of
capturing NPs after administration. Nevertheless, the
importance to understand structure–activity relations
linking NPs and proteins adsorbed on their surface
to physiological responses is needed for effective bio-
medical application of NPs. Improving the ability to
predict the biological outcomes of NPs will speed up
their translation to the clinic. As a matter of facts,
the recognition of specific sequences of peptides
drives key biological processes, such as receptor-
mediated cellular association, particle retention in tis-
sues and organs, and ability (or inability) to cross
biological barriers. To date, we are still unable to
decipher the mechanisms regulating the interaction
between PC-covered NPs and biological systems and
more studies are needed. Deciphering the biological
recognition between PC proteins and cell receptors
could help us understand exactly how protein-
decorated NPs interact with cells and biological bar-
riers, potentially activating different biological
pathways.90
CONCLUSION AND FUTURE
PROSPECTIVE
The last 20 years of research in nanomedicines have
taught us that the composition of the nanoparticle
itself was the most important keystone impacting the
destiny of NPs. Nowadays, we must be aware that
nanoparticles are not only formed by ‘polymers and
drugs’, but are associated with proteins, stably or
weakly adsorbed onto their surface. Nanoparticles
and their PC are new ‘biological entities’.91 These
interactions strongly impacts (maybe more than the
composition of the nanoparticles, size, and shapes)
their safety and functionality performances.
Since this concept is relatively new, a number
of issues are now up for debate:
1. Is the physiological response of a nanomedicine
(meaning drug delivery system + associated
PC) influenced by the whole PC or only a
subset?
2. Are the protein belonging to the SC implicated
in physiological response or not?
3. Are the technologies suitable and sufficient to
discriminate and describe the HC, SC, or both?
4. What competences and skills are needed to
completely understand the impact of the PC on
the destiny of nanomedicines?
To-date, many of these questions are almost com-
pletely unsolved, but some indications and future
direction could be hypothesized.
Firstly, it is reliable that the whole PC influ-
ences the biodistribution of PC–NPs complexes, but
it could be hypothesized that some specific NP trop-
isms or accumulation could be due to a selective
interaction of a subset of the associated PC with spe-
cific cells or receptors.
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Moreover, the most debated aspect of the PC
‘area’ is the role of the SC and HC in determining
biological effects. Some authors hypothesize that the
SC is not pivotal in governing the biological destiny
of nanomedicines, other authors are fully convinced
of the contrary while some others researchers
described the role of the SC of a minor importance
with respect to the role of the HC.
A clear knowledge of these aspects is critical
since it could strongly help in designing nanomater-
ials able to interact with proteins and cells in a con-
trolled way.92,93 As a consequence of the lack of this
knowledge, most nanomedicine are created specifi-
cally aiming to suppress protein adsorption. This
would reduce off-target cell uptake, but also lowers
targeting efficiency.94,95
Another important lack in PC research is con-
nected with technologies. PC–NPs complexes could
be characterized by integrating information on mor-
phology (imaging-spectroscopy-scattering based tech-
niques)41 and on structure/composition of the PC
(cryo-electron microscopy and protein crystallogra-
phy).15 Thus, multi-disciplinary approaches are
needed in order to obtain much more information
about the PC and its properties to fully understand
the real impact of the PC on nanomedicines, and
therefore to better support a more safety and con-
scious application of nanotechnology in medicine.
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